{"id":"W2137990944","doi":"10.1186/1756-8722-3-8","title":"From basic research to clinical development of MEK1/2 inhibitors for cancer therapy","year":2010,"lang":"en","type":"review","venue":"Journal of Hematology & Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":244,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cancer research; Regulator; Cancer; Kinase; Receptor tyrosine kinase; MAPK/ERK pathway; Hematology; Tyrosine kinase; Signal transduction; Function (biology); Hyperactivation; Medicine; Biology; Internal medicine; Cell biology; Gene; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00337264,0.0003296162,0.002928101,0.0003398744,0.00009118459,0.000007916285,0.000798168,0.001972544,0.00006939787],"category_scores_gemma":[0.0008034293,0.0002409176,0.0008023123,0.0001557138,0.0002611871,0.000003368598,0.0002377217,0.001123783,0.00001461433],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008373987,"about_ca_system_score_gemma":0.005838048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000107677,"about_ca_topic_score_gemma":0.0001874918,"domain_scores_codex":[0.995492,0.0008636026,0.002436747,0.0004790915,0.0002567903,0.0004717121],"domain_scores_gemma":[0.9958784,0.0009472509,0.001626813,0.0004338222,0.0008407733,0.0002729563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003798131,0.0003502489,0.0001090451,0.0006378561,0.0007219483,0.00004166293,0.000136578,1.194199e-7,0.002999147,0.00007270773,0.02677259,0.9677783],"study_design_scores_gemma":[0.000922996,0.002415407,0.00001197216,0.0009634682,0.0001672248,0.0002946741,0.00004894797,8.859757e-8,0.009611187,0.00009695093,0.9852634,0.0002036797],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02971811,0.9650728,0.000282555,0.0002955501,0.003567605,0.0008392641,0.00007166103,0.000002821783,0.0001496988],"genre_scores_gemma":[0.0002349167,0.9828714,0.01321102,0.0001591959,0.003019625,0.000205882,0.00007640992,0.00006048927,0.0001610545],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9675746,"threshold_uncertainty_score":0.9997979,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.233354112101503,"score_gpt":0.5308665528212848,"score_spread":0.2975124407197818,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}